Immutep Ltd Adr Stock Revenue
| IMMP Stock | USD 1.82 0.04 2.25% |
Immutep Ltd ADR fundamentals help investors to digest information that contributes to Immutep's financial success or failures. It also enables traders to predict the movement of Immutep Stock. The fundamental analysis module provides a way to measure Immutep's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Immutep stock.
Immutep |
Immutep Ltd ADR Company Revenue Analysis
Immutep's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Immutep Revenue | 3.84 M |
Most of Immutep's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Immutep Ltd ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Immutep Ltd ADR reported 3.84 M of revenue. This is 99.95% lower than that of the Biotechnology sector and 99.48% lower than that of the Health Care industry. The revenue for all United States stocks is 99.96% higher than that of the company.
Immutep Ltd ADR is rated second overall in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 31.18 Million. Immutep retains roughly 3.84 Million in revenue claiming about 12% of equities under Health Care industry.Immutep Fundamentals
| Return On Equity | -0.3 | ||||
| Return On Asset | -0.2 | ||||
| Operating Margin | (8.39) % | ||||
| Current Valuation | 161.73 M | ||||
| Shares Outstanding | 145.56 M | ||||
| Shares Owned By Insiders | 0.01 % | ||||
| Shares Owned By Institutions | 2.05 % | ||||
| Number Of Shares Shorted | 5.09 M | ||||
| Price To Earning | (152.55) X | ||||
| Price To Book | 2.37 X | ||||
| Price To Sales | 53.45 X | ||||
| Revenue | 3.84 M | ||||
| Gross Profit | (41.56 M) | ||||
| EBITDA | (44.54 M) | ||||
| Net Income | (42.72 M) | ||||
| Cash And Equivalents | 80 M | ||||
| Cash Per Share | 0.92 X | ||||
| Total Debt | 1.59 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 14.16 X | ||||
| Book Value Per Share | 0.12 X | ||||
| Cash Flow From Operations | (34.82 M) | ||||
| Short Ratio | 69.58 X | ||||
| Earnings Per Share | (0.21) X | ||||
| Target Price | 9.5 | ||||
| Beta | 1.98 | ||||
| Market Capitalization | 260.8 M | ||||
| Total Asset | 201.58 M | ||||
| Retained Earnings | (382.65 M) | ||||
| Working Capital | 180.86 M | ||||
| Current Asset | 1.89 M | ||||
| Current Liabilities | 1.04 M | ||||
| Net Asset | 201.58 M |
About Immutep Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Immutep Ltd ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immutep using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immutep Ltd ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Additional Tools for Immutep Stock Analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.